Industry Research Reports
Home > Reports > Service & Software > Global Syndromic Diagnostic Test Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Syndromic Diagnostic Test Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Service & Software
Published Date: 2026-03-31
Pages: 130 Pages
Report ld: 6444888
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Syndromic Diagnostic Test market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Syndromic diagnostic test is a type of medical test that enables the simultaneous detection and identification of multiple pathogens or disease markers associated with a specific syndrome or set of symptoms. Instead of targeting a single pathogen or condition, syndromic tests utilize advanced technologies like multiplex PCR, microarrays, or next-generation sequencing to identify a range of pathogens or genetic markers in a single analysis. These tests are particularly useful in situations where the exact cause of an illness is unknown or when there is a possibility of multiple disease agents contributing to the symptoms.
From a downstream perspective, Hospital accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Syndromic Diagnostic Test leading players (including Abbott, Hologic, Applied BioCode, Danaher, Diagenode, Curetis, Bio-Rad, DiaSorin, bioMérieux, QIAGEN, etc.), dominate supply; the top five capture approximately % of global revenue, with Abbott leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Syndromic Diagnostic Test market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Abbott
- Hologic
- Applied BioCode
- Danaher
- Diagenode
- Curetis
- Bio-Rad
- DiaSorin
- bioMérieux
- QIAGEN
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Nucleic Acid Extraction Test
- Polymerase Chain Reaction (PCR) Test
- Others
Segment by Application
- Hospital
- Laboratory
- Research Institution
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Syndromic Diagnostic Test study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Syndromic Diagnostic Test: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Syndromic Diagnostic Test Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Nucleic Acid Extraction Test
1.2.3 Polymerase Chain Reaction (PCR) Test
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Syndromic Diagnostic Test Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Research Institution
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Syndromic Diagnostic Test Revenue Estimates and Forecasts (2021-2032)
2.2 Global Syndromic Diagnostic Test Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Syndromic Diagnostic Test Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Syndromic Diagnostic Test Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Nucleic Acid Extraction Test: Market Share by Key Players
3.3.2 Polymerase Chain Reaction (PCR) Test: Market Share by Key Players
3.3.3 Others: Market Share by Key Players
3.4 Global Syndromic Diagnostic Test Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Syndromic Diagnostic Test Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Syndromic Diagnostic Test Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Syndromic Diagnostic Test Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Syndromic Diagnostic Test Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Syndromic Diagnostic Test Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Syndromic Diagnostic Test Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Syndromic Diagnostic Test Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Syndromic Diagnostic Test Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Syndromic Diagnostic Test Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Syndromic Diagnostic Test Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Syndromic Diagnostic Test Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Syndromic Diagnostic Test Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Syndromic Diagnostic Test Product Features and Attributes
11.1.4 Abbott Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
11.1.5 Abbott Syndromic Diagnostic Test Revenue by Product in 2025
11.1.6 Abbott Syndromic Diagnostic Test Revenue by Application in 2025
11.1.7 Abbott Syndromic Diagnostic Test Revenue by Geographic Area in 2025
11.1.8 Abbott Syndromic Diagnostic Test SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 Hologic
11.2.1 Hologic Corporation Information
11.2.2 Hologic Business Overview
11.2.3 Hologic Syndromic Diagnostic Test Product Features and Attributes
11.2.4 Hologic Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
11.2.5 Hologic Syndromic Diagnostic Test Revenue by Product in 2025
11.2.6 Hologic Syndromic Diagnostic Test Revenue by Application in 2025
11.2.7 Hologic Syndromic Diagnostic Test Revenue by Geographic Area in 2025
11.2.8 Hologic Syndromic Diagnostic Test SWOT Analysis
11.2.9 Hologic Recent Developments
11.3 Applied BioCode
11.3.1 Applied BioCode Corporation Information
11.3.2 Applied BioCode Business Overview
11.3.3 Applied BioCode Syndromic Diagnostic Test Product Features and Attributes
11.3.4 Applied BioCode Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
11.3.5 Applied BioCode Syndromic Diagnostic Test Revenue by Product in 2025
11.3.6 Applied BioCode Syndromic Diagnostic Test Revenue by Application in 2025
11.3.7 Applied BioCode Syndromic Diagnostic Test Revenue by Geographic Area in 2025
11.3.8 Applied BioCode Syndromic Diagnostic Test SWOT Analysis
11.3.9 Applied BioCode Recent Developments
11.4 Danaher
11.4.1 Danaher Corporation Information
11.4.2 Danaher Business Overview
11.4.3 Danaher Syndromic Diagnostic Test Product Features and Attributes
11.4.4 Danaher Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
11.4.5 Danaher Syndromic Diagnostic Test Revenue by Product in 2025
11.4.6 Danaher Syndromic Diagnostic Test Revenue by Application in 2025
11.4.7 Danaher Syndromic Diagnostic Test Revenue by Geographic Area in 2025
11.4.8 Danaher Syndromic Diagnostic Test SWOT Analysis
11.4.9 Danaher Recent Developments
11.5 Diagenode
11.5.1 Diagenode Corporation Information
11.5.2 Diagenode Business Overview
11.5.3 Diagenode Syndromic Diagnostic Test Product Features and Attributes
11.5.4 Diagenode Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
11.5.5 Diagenode Syndromic Diagnostic Test Revenue by Product in 2025
11.5.6 Diagenode Syndromic Diagnostic Test Revenue by Application in 2025
11.5.7 Diagenode Syndromic Diagnostic Test Revenue by Geographic Area in 2025
11.5.8 Diagenode Syndromic Diagnostic Test SWOT Analysis
11.5.9 Diagenode Recent Developments
11.6 Curetis
11.6.1 Curetis Corporation Information
11.6.2 Curetis Business Overview
11.6.3 Curetis Syndromic Diagnostic Test Product Features and Attributes
11.6.4 Curetis Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
11.6.5 Curetis Recent Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Corporation Information
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Syndromic Diagnostic Test Product Features and Attributes
11.7.4 Bio-Rad Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
11.7.5 Bio-Rad Recent Developments
11.8 DiaSorin
11.8.1 DiaSorin Corporation Information
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Syndromic Diagnostic Test Product Features and Attributes
11.8.4 DiaSorin Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
11.8.5 DiaSorin Recent Developments
11.9 bioMérieux
11.9.1 bioMérieux Corporation Information
11.9.2 bioMérieux Business Overview
11.9.3 bioMérieux Syndromic Diagnostic Test Product Features and Attributes
11.9.4 bioMérieux Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
11.9.5 bioMérieux Recent Developments
11.10 QIAGEN
11.10.1 QIAGEN Corporation Information
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Syndromic Diagnostic Test Product Features and Attributes
11.10.4 QIAGEN Syndromic Diagnostic Test Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
12 Syndromic Diagnostic Test Value Chain and Ecosystem Analysis
12.1 Syndromic Diagnostic Test Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Syndromic Diagnostic Test Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Syndromic Diagnostic Test Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Syndromic Diagnostic Test Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Syndromic Diagnostic Test Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Syndromic Diagnostic Test Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Syndromic Diagnostic Test Revenue by Region (US$ Million), 2021-2026
Table 5. Global Syndromic Diagnostic Test Revenue by Region (US$ Million), 2027-2032
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 7. Global Syndromic Diagnostic Test Revenue by Players (US$ Million), 2021-2026
Table 8. Global Syndromic Diagnostic Test Revenue-Based Market Share by Players (2021-2026)
Table 9. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 10. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Syndromic Diagnostic Test Revenue, 2025
Table 11. Global Syndromic Diagnostic Test Average Gross Margin (%) by Player (2021 vs 2025)
Table 12. Global Syndromic Diagnostic Test Companies Headquarters
Table 13. Global Syndromic Diagnostic Test Market Concentration Ratio (CR5)
Table 14. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Syndromic Diagnostic Test Revenue by Type (US$ Million), 2021-2026
Table 17. Global Syndromic Diagnostic Test Revenue by Type (US$ Million), 2027-2032
Table 18. Key Product Attributes and Differentiation
Table 19. Global Syndromic Diagnostic Test Revenue by Application (US$ Million), 2021-2026
Table 20. Global Syndromic Diagnostic Test Revenue by Application (US$ Million), 2027-2032
Table 21. Syndromic Diagnostic Test High-Growth Sectors Demand CAGR (2026-2032)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Syndromic Diagnostic Test Growth Accelerators and Market Barriers
Table 25. North America Syndromic Diagnostic Test Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 26. Europe Syndromic Diagnostic Test Growth Accelerators and Market Barriers
Table 27. Europe Syndromic Diagnostic Test Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. Asia-Pacific Syndromic Diagnostic Test Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Syndromic Diagnostic Test Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 30. Central and South America Syndromic Diagnostic Test Investment Opportunities and Key Challenges
Table 31. Central and South America Syndromic Diagnostic Test Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Middle East and Africa Syndromic Diagnostic Test Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Syndromic Diagnostic Test Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 34. Abbott Corporation Information
Table 35. Abbott Description and Major Businesses
Table 36. Abbott Product Features and Attributes
Table 37. Abbott Revenue (US$ Million) and Gross Margin (2021-2026)
Table 38. Abbott Revenue Proportion by Product in 2025
Table 39. Abbott Revenue Proportion by Application in 2025
Table 40. Abbott Revenue Proportion by Geographic Area in 2025
Table 41. Abbott Syndromic Diagnostic Test SWOT Analysis
Table 42. Abbott Recent Developments
Table 43. Hologic Corporation Information
Table 44. Hologic Description and Major Businesses
Table 45. Hologic Product Features and Attributes
Table 46. Hologic Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. Hologic Revenue Proportion by Product in 2025
Table 48. Hologic Revenue Proportion by Application in 2025
Table 49. Hologic Revenue Proportion by Geographic Area in 2025
Table 50. Hologic Syndromic Diagnostic Test SWOT Analysis
Table 51. Hologic Recent Developments
Table 52. Applied BioCode Corporation Information
Table 53. Applied BioCode Description and Major Businesses
Table 54. Applied BioCode Product Features and Attributes
Table 55. Applied BioCode Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. Applied BioCode Revenue Proportion by Product in 2025
Table 57. Applied BioCode Revenue Proportion by Application in 2025
Table 58. Applied BioCode Revenue Proportion by Geographic Area in 2025
Table 59. Applied BioCode Syndromic Diagnostic Test SWOT Analysis
Table 60. Applied BioCode Recent Developments
Table 61. Danaher Corporation Information
Table 62. Danaher Description and Major Businesses
Table 63. Danaher Product Features and Attributes
Table 64. Danaher Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. Danaher Revenue Proportion by Product in 2025
Table 66. Danaher Revenue Proportion by Application in 2025
Table 67. Danaher Revenue Proportion by Geographic Area in 2025
Table 68. Danaher Syndromic Diagnostic Test SWOT Analysis
Table 69. Danaher Recent Developments
Table 70. Diagenode Corporation Information
Table 71. Diagenode Description and Major Businesses
Table 72. Diagenode Product Features and Attributes
Table 73. Diagenode Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Diagenode Revenue Proportion by Product in 2025
Table 75. Diagenode Revenue Proportion by Application in 2025
Table 76. Diagenode Revenue Proportion by Geographic Area in 2025
Table 77. Diagenode Syndromic Diagnostic Test SWOT Analysis
Table 78. Diagenode Recent Developments
Table 79. Curetis Corporation Information
Table 80. Curetis Description and Major Businesses
Table 81. Curetis Product Features and Attributes
Table 82. Curetis Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Curetis Recent Developments
Table 84. Bio-Rad Corporation Information
Table 85. Bio-Rad Description and Major Businesses
Table 86. Bio-Rad Product Features and Attributes
Table 87. Bio-Rad Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Bio-Rad Recent Developments
Table 89. DiaSorin Corporation Information
Table 90. DiaSorin Description and Major Businesses
Table 91. DiaSorin Product Features and Attributes
Table 92. DiaSorin Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. DiaSorin Recent Developments
Table 94. bioMérieux Corporation Information
Table 95. bioMérieux Description and Major Businesses
Table 96. bioMérieux Product Features and Attributes
Table 97. bioMérieux Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. bioMérieux Recent Developments
Table 99. QIAGEN Corporation Information
Table 100. QIAGEN Description and Major Businesses
Table 101. QIAGEN Product Features and Attributes
Table 102. QIAGEN Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. QIAGEN Recent Developments
Table 104. Technologies, Platforms and Infrastructure
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Syndromic Diagnostic Test Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Nucleic Acid Extraction Test Product Picture
Figure 3. Polymerase Chain Reaction (PCR) Test Product Picture
Figure 4. Others Product Picture
Figure 5. Global Syndromic Diagnostic Test Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Global Syndromic Diagnostic Test Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Hospital
Figure 8. Laboratory
Figure 9. Research Institution
Figure 10. Others
Figure 11. Syndromic Diagnostic Test Report Years Considered
Figure 12. Global Syndromic Diagnostic Test Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 14. Global Syndromic Diagnostic Test Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Global Syndromic Diagnostic Test Revenue-Based Market Share by Region (2021-2032)
Figure 16. Global Syndromic Diagnostic Test Revenue-Based Market Share Ranking (2025)
Figure 17. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 18. Nucleic Acid Extraction Test Revenue-Based Market Share by Player in 2025
Figure 19. Polymerase Chain Reaction (PCR) Test Revenue-Based Market Share by Player in 2025
Figure 20. Others Revenue-Based Market Share by Player in 2025
Figure 21. Global Syndromic Diagnostic Test Revenue-Based Market Share by Type (2021-2032)
Figure 22. Global Syndromic Diagnostic Test Revenue-Based Market Share by Application (2021-2032)
Figure 23. North America Syndromic Diagnostic Test Revenue YoY (US$ Million), 2021-2032
Figure 24. North America Top 5 Players Syndromic Diagnostic Test Revenue (US$ Million) in 2025
Figure 25. North America Syndromic Diagnostic Test Revenue (US$ Million) by Application (2021-2032)
Figure 26. US Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 27. Canada Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 28. Mexico Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 29. Europe Syndromic Diagnostic Test Revenue YoY (US$ Million), 2021-2032
Figure 30. Europe Top 5 Players Syndromic Diagnostic Test Revenue (US$ Million) in 2025
Figure 31. Europe Syndromic Diagnostic Test Revenue (US$ Million) by Application (2021-2032)
Figure 32. Germany Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 33. France Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 34. U.K. Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 35. Italy Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 36. Russia Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 37. Asia-Pacific Syndromic Diagnostic Test Revenue YoY (US$ Million), 2021-2032
Figure 38. Asia-Pacific Top 8 Players Syndromic Diagnostic Test Revenue (US$ Million) in 2025
Figure 39. Asia-Pacific Syndromic Diagnostic Test Revenue (US$ Million) by Application (2021-2032)
Figure 40. Indonesia Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 41. Japan Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 42. South Korea Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 43. Australia Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 44. India Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 45. Indonesia Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 46. Vietnam Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 47. Malaysia Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 48. Philippines Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 49. Singapore Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 50. Central and South America Syndromic Diagnostic Test Revenue YoY (US$ Million), 2021-2032
Figure 51. Central and South America Top 5 Players Syndromic Diagnostic Test Revenue (US$ Million) in 2025
Figure 52. Central and South America Syndromic Diagnostic Test Revenue (US$ Million) by Application (2021-2032)
Figure 53. Brazil Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 54. Argentina Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 55. Middle East and Africa Syndromic Diagnostic Test Revenue YoY (US$ Million), 2021-2032
Figure 56. Middle East and Africa Top 5 Players Syndromic Diagnostic Test Revenue (US$ Million) in 2025
Figure 57. Middle East and Africa Syndromic Diagnostic Test Revenue (US$ Million) by Application (2021-2032)
Figure 58. GCC Countries Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 59. Israel Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 60. Egypt Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 61. South Africa Syndromic Diagnostic Test Revenue (US$ Million), 2021-2032
Figure 62. Syndromic Diagnostic Test Value Chain Mapping
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Syndromic Diagnostic Test market?
The top companies in the global Syndromic Diagnostic Test market are Abbott、Hologic、Applied BioCode.
Related Reports
Global Syndromic Diagnostic Test Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Syndromic Diagnostic Test market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 79
USD 4250.00
(Single User License)
Syndromic Diagnostic Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Syndromic Diagnostic Test was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 87
USD 3950.00
(Single User License)
Global Syndromic Diagnostic Test Market Research Report 2026
The global Syndromic Diagnostic Test market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 109
USD 2900.00
(Single User License)
Global Syndromic Diagnostic Test Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Syndromic Diagnostic Test market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-02
Pages: 116
USD 4900.00
(Single User License)
Global Syndromic Diagnostic Test Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Syndromic Diagnostic Test market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 77
USD 4250.00
(Single User License)
Syndromic Diagnostic Test- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Syndromic Diagnostic Test was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 89
USD 3950.00
(Single User License)
Global Syndromic Diagnostic Test Market Research Report 2025
The global market for Syndromic Diagnostic Test was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 78
USD 2900.00
(Single User License)
Global Syndromic Diagnostic Test Market Insights, Forecast to 2030
Syndromic diagnostic test is a type of medical test that enables the simultaneous detection and identification of multiple pathogens or disease markers associated with a specific syndrome or set of symptoms. Instead of targeting a single pathogen or condition, syndromic tests utilize advanced technologies like multiplex PCR, microarrays, or next-generation sequencing to identify a range of pathogens or genetic markers in a single analysis. These tests are particularly useful in situations where the exact cause of an illness is unknown or when there is a possibility of multiple disease agents contributing to the symptoms.
Published Date: 2024-02-04
Pages: 113
USD 4900.00
(Single User License)
Global Syndromic Diagnostic Test Market Research Report 2024
Syndromic diagnostic test is a type of medical test that enables the simultaneous detection and identification of multiple pathogens or disease markers associated with a specific syndrome or set of symptoms. Instead of targeting a single pathogen or condition, syndromic tests utilize advanced technologies like multiplex PCR, microarrays, or next-generation sequencing to identify a range of pathogens or genetic markers in a single analysis. These tests are particularly useful in situations where the exact cause of an illness is unknown or when there is a possibility of multiple disease agents contributing to the symptoms.
Published Date: 2024-01-26
Pages: 86
USD 2900.00
(Single User License)
Global and India Syndromic Diagnostic Test Market Report & Forecast 2024-2030
Syndromic diagnostic test is a type of medical test that enables the simultaneous detection and identification of multiple pathogens or disease markers associated with a specific syndrome or set of symptoms. Instead of targeting a single pathogen or condition, syndromic tests utilize advanced technologies like multiplex PCR, microarrays, or next-generation sequencing to identify a range of pathogens or genetic markers in a single analysis. These tests are particularly useful in situations where the exact cause of an illness is unknown or when there is a possibility of multiple disease agents contributing to the symptoms.
Published Date: 2024-01-26
Pages: 120
USD 4350.00
(Single User License)
Global Syndromic Diagnostic Test Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Syndromic Diagnostic Test market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 79
USD 4250.00 (Single User License)Syndromic Diagnostic Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Syndromic Diagnostic Test was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 87
USD 3950.00 (Single User License)Global Syndromic Diagnostic Test Market Research Report 2026
The global Syndromic Diagnostic Test market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 109
USD 2900.00 (Single User License)Global Syndromic Diagnostic Test Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Syndromic Diagnostic Test market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-02
Pages: 116
USD 4900.00 (Single User License)Global Syndromic Diagnostic Test Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Syndromic Diagnostic Test market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 77
USD 4250.00 (Single User License)Syndromic Diagnostic Test- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Syndromic Diagnostic Test was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 89
USD 3950.00 (Single User License)Global Syndromic Diagnostic Test Market Research Report 2025
The global market for Syndromic Diagnostic Test was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 78
USD 2900.00 (Single User License)Global Syndromic Diagnostic Test Market Insights, Forecast to 2030
Syndromic diagnostic test is a type of medical test that enables the simultaneous detection and identification of multiple pathogens or disease markers associated with a specific syndrome or set of symptoms. Instead of targeting a single pathogen or condition, syndromic tests utilize advanced technologies like multiplex PCR, microarrays, or next-generation sequencing to identify a range of pathogens or genetic markers in a single analysis. These tests are particularly useful in situations where the exact cause of an illness is unknown or when there is a possibility of multiple disease agents contributing to the symptoms.
Published: 2024-02-04
Pages: 113
USD 4900.00 (Single User License)Global Syndromic Diagnostic Test Market Research Report 2024
Syndromic diagnostic test is a type of medical test that enables the simultaneous detection and identification of multiple pathogens or disease markers associated with a specific syndrome or set of symptoms. Instead of targeting a single pathogen or condition, syndromic tests utilize advanced technologies like multiplex PCR, microarrays, or next-generation sequencing to identify a range of pathogens or genetic markers in a single analysis. These tests are particularly useful in situations where the exact cause of an illness is unknown or when there is a possibility of multiple disease agents contributing to the symptoms.
Published: 2024-01-26
Pages: 86
USD 2900.00 (Single User License)Global and India Syndromic Diagnostic Test Market Report & Forecast 2024-2030
Syndromic diagnostic test is a type of medical test that enables the simultaneous detection and identification of multiple pathogens or disease markers associated with a specific syndrome or set of symptoms. Instead of targeting a single pathogen or condition, syndromic tests utilize advanced technologies like multiplex PCR, microarrays, or next-generation sequencing to identify a range of pathogens or genetic markers in a single analysis. These tests are particularly useful in situations where the exact cause of an illness is unknown or when there is a possibility of multiple disease agents contributing to the symptoms.
Published: 2024-01-26
Pages: 120
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now